Autophagy Gene Activity May Act As a Key Factor for Sensitivity of Tumor Cells to Oncolytic Vesicular Stomatitis Virus
Main Authors: | Nabizadeh, Arezoo, Bamdad, Taravat, Arefian, Ehsan, Razavi Nikoo, Seyed Hadi |
---|---|
Format: | Online |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922204/ |
Similar Items
-
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
by: Muik, Alexander, et al.
Published: (2012) -
Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy
by: Simovic, Boris, et al.
Published: (2015) -
Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta
by: Naik, Shruthi, et al.
Published: (2012) -
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines
by: Bridle, Byram W, et al.
Published: (2013) -
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer
by: Heiber, Joshua F., et al.
Published: (2011)